CLINICAL_TRIALS
research
· 2017-10-17
Clinical Trial Update: Evaluation of the Role of Aflatoxin as an Environmental Risk Factor Attributable to Liver Cancer in Nile Delta [NA]
Summary
Clinical trial evaluating aflatoxin as an environmental risk factor for liver cancer; the study is completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Sherief Abd-Elsalam | Conditions: Liver Cancer | NA | Status: COMPLETED | Results posted: 2017-10-17